Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome

Clinical Endocrinology

Volumn 47, Issue 1, 1997, Pages 93-99

  Gilling Smith, C ^a   Story, H ^a   Rogers, V ^a   Franks, S ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CONJUGATED ESTROGEN; GONADORELIN DERIVATIVE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROIDOGENESIS; THECA CELL;

EID: 0030832255     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2321049.x     Document Type: Article

References (37)

1. Adams, J., Polson, D.W. & Franks, S., (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsuitism. British Medical Journal, 293, 355-359.
2. Azziz, R. (1993) The role of the ovary in the genesis of hyperandrogenism. In The Ovary (eds. E.Y. Adashi & P.C.K. Leung), pp. 581-605. Raven Press, New York.
3. Barbien, R.L., Makris, A., Randall, R.W., Daniells, G., Kistner, R.W. & Ryan, K.J. (1986) Insulin stimulates androgen accumulation in incubations of human ovarian stroma obtained from women with hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 62, 921-925.
4. Barbieri, R.L. & Ryan, K.J. (1991) Polycystic ovarian disease. Annual Reviews in Medicine, 42, 199-204.
5. Barnes, R.B., Rosenfield, R.L., Burstein, S. & Erhmann, D.A. (1989) Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. New England Journal of Medicine, 320, 559-565.
6. Baulieu, E.E., Mauvais-Jarvis, P. & Corpéchot, C. (1963) Steroid studies in a case of Stein-Leventhal syndrome with hirsutism. Journal of Clinical Endocrinology, 23, 374-382.
7. Bogovich, K. & Richards, J.S. (1982) Androgen biosynthesis in developing ovarian follicles: evidence that luteinizing hormone regulates theca 17α-hydroxylase and C-17,20 lyase activities. Endocrinology, 111, 1201-1208.
8. Chang, R.J., Laufer, L.R., Meldrum, D.R., Defazio, J., Lu, J.K.H., Vale, W.W., Rivier, J.E. & Judd, H.L. (1983) Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotrophin-releasing hormone agonist. Journal of Clinical Endocrinology and Metabolism, 56, 897-903.
9. Conway, G.S., Honour, J.W. & Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology, 30, 459-470.
10. Couzinet, B., Le Strat, N., Brailly, S. & Schaison, G. (1986) Comparative effects of cyproterone acetate or a long-acting gonadotrophin-releasing hormone agonist in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 63, 1031-1035.
11. Dunaif, A., Shelley, D., Green, G., Dobrjansky, A. & Licholai, T. (1992) Evidence for distinctive and intrinsic defects in insulin action in the polycystic ovary syndrome. Diabetes, 41, 1257-1266.
12. Eckstein, B., Greenbaum, O. & Cohen, S. (1985) Kinetic studies on ovarian C-17,20-lyase activity: effect of luteinizing hormone surge. Endocrinology, 117, 2376-2382.
13. Ferriman, D. & Gallwey, J.D. (1961) Clinical measurement of body hair growth in women. Journal of Clinical Endocrinology and Metabolism, 21, 1440-1447.
14. Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clinical Endocrinology, 31, 87-120.
15. Franks, S. (1991) The ubiquitous polycystic ovary. Journal of Endocrinology, 129, 317-319.
16. Franks, S. (1995) Medical progress: polycystic ovary syndrome. New England Journal of Medicine, 333, 853-861.
17. Gilling-Smith, C., Willis, D., Beard, R. & Franks, S. (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism, 79, 1158-1165.
18. Horrocks, P.M., Kandeel, F.R., London, D.R., Butt, W.R., Lynch, S.S., Holder, G. & Logan-Edwards, R. (1983) ACTH function in women with the polycystic ovary syndrome. Clinical Endocrinology, 19, 143-150.
19. Hudson, R.W., Lochnan, H.A., Danby, F.W., Margesson, L.J., Strang, B.K. & Kimmett, S.M. (1990) 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism. Fertility and Sterility, 54, 1065-1071.
20. Kirschner, M.A. & Jacobs, J.B. (1971) Combined ovarian and adrenal vein catheterisation to determine the site(s) of androgen overproduction in hirsute women. Journal of Clinical Endocrinology and Metabolism, 33, 199-209.
21. Levrant, S.G., Barnes, R.B. & Rosenfield, R.L. (1994) hCG-stimulated 17, 20 lyase activity is unaffected by Tamoxifen in PCOS or normal subjects. 76th Annual Meeting of the Endocrine Society, Annaheim, CA. Abstract 837.
22. Lloyd, C.W., Lobotsky, J., Segre, E.J., Koboyashi, T., Taymor, M.L. & Batt, R.E. (1966) Plasma testosterone and urinary 17-ketosteroids in women with hirsutism and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism, 26, 314-324.
23. McAllister, J.J., Kerin, J.F., Trant, J.M., Estabrook, R.W., Mason, J.I., Waterman, M.R. & Simpson, E.R. (1989) Regulation of cholesterol side-chain cleavage and 17 alpha-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. Endocrinology, 125, 1959-1966.
24. McKenna, T.J. (1988) Pathogenesis and treatment of polycystic ovary syndrome. New England Journal of Medicine, 318, 558-562.
25. Milewicz, A., Silber, D. & Mielecki, T. (1983) The origin of androgen synthesis in polycystic ovary syndrome. Obstetrics and Gynecology, 62, 601-604.
26. Moltz, L., Schwartz, U., Sorensen, R., Pickartz, H. & Hammerstein, J. (1984) Ovarian and adrenal vein steroids in patients with non-neoplastic hyperandrogenism. Fertility and Sterility, 42, 69-75.
27. Netter, A., Jayle, M.F., Musset, R., Lambert, A. & Mauvais-Jarvis P. (1960) Les épreuves dynamiques dans le syndrome de Stein-Leventhal. Annals d'Endocrinologie, 21, 590-600.
28. Pugeat, M., Forest, M.G., Nisula, B.C., Corniau, J., De Peretti, E. & Tourmiaire, J. (1982) Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism. Obstetrics and Gynecology, 59, 46-51.
29. Robinson, S., Kiddy, D., Gelding, S.V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D.G. & Franks, S. (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clinical Endocrinology, 39, 351-355.
30. Rosenfield, R.L., Ehrlich, E.N. & Cleary, R.E. (1972) Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. Journal of Clinical Endocrinology and Metabolism, 34, 92-98.
31. Rosenfield, R.L., Barnes, R.B., Cara, J.F. & Lucky, A.W. (1990) Dysregulation of cytochrome P450c17 alpha as the cause of polycystic ovarian syndrome. Fertility and Sterility, 53, 785-791.
32. Rosenfield, R.L., Barnes, R.B. & Ehrmann, D. (1994) Studies of the nature of 17-hydroxyprogesterone hyper-responsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hyper androgenism. Journal of Clinical Endocrinology and Metabolism, 79, 1158-1165.
33. Sharp, P.S., Kiddy, D.S., Reed, M.J., Anyaoku, V., Johnston, D.G. & Franks, S. (1991) Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clinical Endocrinology, 35, 253-257.
34. Steingold, K., De, Z.D., Cedars, M., Meldrum, D.R., Lu, J.K., Judd, H.L. & Chang, R.J. (1987) Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 65, 773-778.
35. Varga, L. & Azokwu, P.H. (1976) The significance of the combined dexamethasone-HCG test for the assessment of hyperandrogenism. Acta Europœa Fertilitatis, 7, 267-279.
36. White, D., Leigh, A., Wilson, C., Donaldson, A. & Franks, S. (1995) Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clinical Endocrinology, 42, 475-481.
37. Yen, S.S.C., Chaney, C. & Judd, H.L. (1976) Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrome; a consideration of the pathogenesis. In The Endocrine Function of the Human Ovary (ed. V.H.T. James, M. Serio & G. Giuisti), pp. 373-385. Academic Press, New York.